Literature DB >> 1443077

Retrolabyrinthine transtentorial approach to lesions of the anterior cerebellopontine angle.

S E Kinney1, G B Hughes, J R Little.   

Abstract

Various surgical approaches to the cerebellopontine angle have been used for removal of acoustic neuromas. A retrolabyrinthine transtentorial approach has been developed that allows (1) access to the anterior cerebellopontine angle and all portions of the basilar artery, (2) extra dural retraction of the lateral sinus and cerebellum while avoiding the vein of Labbé, and (3) preservation of hearing. This approach allows good exposure of tumor and accurate visualization of cranial nerves. To avoid complications, control of spinal fluid is mandatory and great care must be taken to avoid injury of the cranial nerves. The retrolabyrinthine or translabyrinthine transtentorial approach enables skilled neurosurgeons and neurotologists to gain access to lesions that are located in areas difficult to approach.

Entities:  

Mesh:

Year:  1992        PMID: 1443077

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  5 in total

1.  Retrolabyrinthine craniectomy: the unsung hero of skull base surgery.

Authors:  Stephen M Russell; J Thomas Roland; John G Golfinos
Journal:  Skull Base       Date:  2004-02

2.  The vulnerability of the vein of labbé during combined craniotomies of the middle and posterior fossae.

Authors:  L R Lustig; R K Jackler
Journal:  Skull Base Surg       Date:  1998

Review 3.  Evolution and advances of the lateral surgical approaches to cranial base neoplasms.

Authors:  S P Cass; B E Hirsch; M T Stechison
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Radiographic Assessment of the presigmoid retrolabyrinthine approach.

Authors:  Andrew K Wong; Melissa M Stamates; Anita P Bhansali; Michael Shinners; Ricky H Wong
Journal:  Surg Neurol Int       Date:  2017-06-27

Review 5.  Lateral approaches to the skull base.

Authors:  E Zanoletti; A Martini; E Emanuelli; A Mazzoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-10       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.